Eubel Brady & Suttman Asset Management Inc Thermo Fisher Scientific Inc. Transaction History

Eubel Brady & Suttman Asset Management Inc

$766 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$507.19 - $604.49 $31,952 - $38,082	-63 Reduced 13.13%	417 $211,000
Q2 2022 Aug 12, 2022	SELL	$500.9 - $612.21 $7,012 - $8,570	-14 Reduced 2.83%	480 $261,000
Q1 2022 May 16, 2022	SELL	$524.0 - $644.92 $9.44 Million - $11.6 Million	-18,011 Reduced 97.33%	494 $291,000
Q4 2021 Feb 10, 2022	SELL	$569.0 - $667.24 $210,530 - $246,878	-370 Reduced 1.96%	18,505 $12.3 Million
Q3 2021 Nov 05, 2021	BUY	$509.53 - $609.78 $344,442 - $412,211	676 Added 3.71%	18,875 $10.8 Million
Q2 2021 Aug 17, 2021	SELL	$441.0 - $508.24 $8.03 Million - $9.25 Million	-18,199 Reduced 50.0%	18,199 $8.31 Million
Q1 2021 May 14, 2021	BUY	$439.85 - $518.83 $8.23 Million - $9.7 Million	18,703 Added 105.7%	36,398 $16.6 Million
Q4 2020 Feb 12, 2021	SELL	$435.06 - $527.66 $428,969 - $520,272	-986 Reduced 5.28%	17,695 $8.24 Million
Q3 2020 Nov 12, 2020	SELL	$359.77 - $441.52 $5.18 Million - $6.36 Million	-14,402 Reduced 43.53%	18,681 $8.25 Million
Q2 2020 Aug 13, 2020	SELL	$275.2 - $362.34 $108,153 - $142,399	-393 Reduced 1.17%	33,083 $12 Million
Q1 2020 May 13, 2020	SELL	$255.3 - $340.05 $63,569 - $84,672	-249 Reduced 0.74%	33,476 $9.49 Million
Q4 2019 Feb 11, 2020	SELL	$271.93 - $328.04 $718,167 - $866,353	-2,641 Reduced 7.26%	33,725 $11 Million
Q3 2019 Nov 12, 2019	SELL	$268.46 - $305.43 $429,804 - $488,993	-1,601 Reduced 4.22%	36,366 $10.6 Million
Q2 2019 Aug 12, 2019	SELL	$257.51 - $295.55 $257,510 - $295,550	-1,000 Reduced 2.57%	37,967 $11.2 Million
Q1 2019 May 15, 2019	SELL	$212.17 - $273.72 $239,752 - $309,303	-1,130 Reduced 2.82%	38,967 $10.7 Million
Q4 2018 Feb 14, 2019	SELL	$208.47 - $251.98 $195,753 - $236,609	-939 Reduced 2.29%	40,097 $8.97 Million
Q3 2018 Nov 15, 2018	SELL	$205.57 - $244.32 $384,004 - $456,389	-1,868 Reduced 4.35%	41,036 $10 Million
Q2 2018 Aug 14, 2018	SELL	$203.14 - $219.53 $267,738 - $289,340	-1,318 Reduced 2.98%	42,904 $8.89 Million
Q1 2018 May 15, 2018	SELL	$192.98 - $224.11 $115,980 - $134,690	-601 Reduced 1.34%	44,222 $9.13 Million
Q4 2017 Feb 14, 2018	SELL	$182.03 - $200.37 $1.97 Million - $2.16 Million	-10,799 Reduced 19.41%	44,823 $8.51 Million
Q3 2017 Nov 14, 2017	SELL	$171.74 - $194.04 $437,937 - $494,802	-2,550 Reduced 4.38%	55,622 $10.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	58,172	58,172 $10.1 Million

Others Institutions Holding TMO

# of Institutions

2,829

Shares Held

334M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eubel Brady & Suttman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eubel Brady & Suttman Asset Management Inc with notifications on news.

Account